Rexall Rexall Nic-Assist Stop Smoking System Step 2 14mg

7 Count

$26.96

Rexall

Rexall Nic-Assist Stop Smoking System Step 2 14mg

7 Count
  • bvseo_sdk, p_sdk, 3.2.1
  • CLOUD, getAggregateRating, 32.26ms
  • REVIEWS, PRODUCT
  • bvseo-msg: HTTP status code of 404 was returned;

$26.96

Discontinued
+
Description

The transdermal Nicotine Patch controlled-release technology is based on a continuous 24-hour flow of nicotine. This continuous release helps keep your cigarette cravings at bay, no matter what time of day you usually smoke. The transdermal Nicotine Patch is intended to be used as part of a smoking cessation strategy. The transdermal Nicotine Patch is indicated as a temporary aid used to facilitate smoking cessation in smokers who strongly desire to give up their smoking habit. To be sure this product is right for you, always read and follow the label.

Recommended Dosage:
If you smoke more than 10 cigarettes per day, wear one 21 mg patch (Step 1) daily for 4 weeks before moving on to step 2. If you've completed Step 1 of the program, using the 21mg patch, then wear one 14mg patch daily for 2 weeks before moving to Step 3. For the last 2 weeks of the program, wear one 7mg patch daily. If you smoke up to 10 cigarettes per day: Start with the 14mg patch (Step 2) and wear one 14mg patch daily for 6 weeks before moving to Step 3. For the last 2 weeks of the program, wear one 7mg patch daily.

Medicinal Ingredients: EACH TRANSDERMAL NICOTINE PATCH 14mg/DAY CONTAINS: 35.0 mg of nicotine with a nominal controlled release rate in vivo of 14.0 mg/24hr. Non-medicinal Ingredients: Acrylate Vinylacetate Copolymers, Medium-chain Triglycerides, Basic butylated methacrylate copolymer.

Should you require consultation with a pharmacist, you may contact our Well.ca Pharmacist. Please read the label, warnings and inserts provided by the manufacturer and consult your healthcare professional when purchasing medications or natural health products to be sure the product is right for you.

Highlights
Canadian product

Ingredients
EACH TRANSDERMAL NICOTINE PATCH 14mg/DAY CONTAINS: 35.0 mg of nicotine with a nominal controlled release rate in vivo of 14.0 mg/24hr. Acrylate Vinylacetate Copolymers, Medium-chain Triglycerides, Basic butylated methacrylate copolymer
Shipping & Returns
  • We are only able to ship this item to Canadian customers.
Click here for more information
  • bvseo_sdk, p_sdk, 3.2.1
  • CLOUD, getReviews, 4.01ms
  • REVIEWS, PRODUCT
  • bvseo-msg: HTTP status code of 404 was returned; HTTP status code of 404 was returned;